XML 24 R13.htm IDEA: XBRL DOCUMENT
v3.7.0.1

Stockholders' Equity | 6 Months Ended
--- | ---
May 31, 2017
Equity [Abstract] |
Stockholders' Equity | Note 8 – Stockholders’ Equity Employee Stock Incentive Plan The Company maintains the 2006 Stock Incentive Plan (the “2006 Plan”) under which it has reserved 1,000,000 shares of the Company’s common stock for issuance pursuant to stock options, restricted stock, stock-appreciation rights (commonly referred to as “SARs”) and stock awards (i.e. performance options to purchase shares and performance units). As of May 31, 2017 and November 30, 2016, there were 540,500 and 572,281 options issued, but not yet exercised, under the 2006 Plan, respectively. As of May 31, 2017, there were 231,929 shares available for future issuance under the 2006 Plan. The Company also maintains the 2012 Equity Incentive Plan (the “2012 Plan”) which became effective December 1, 2011 as approved by the Board of Directors and approved by the stockholders at the 2012 Annual Meeting on July 10, 2012. The 2012 Plan originally reserved 1,500,000 shares of the Company’s common stock for issuance pursuant to stock options, restricted stock, SARs, and other stock awards (i.e. performance shares and performance units). In May 2012, the Board of Directors approved an amendment to the 2012 Plan to increase the number of shares of the Company’s common stock reserved for issuance to 2,500,000 shares As of May 31, 2017, there were 569,729 service-based options issued, 129,729 service-based restricted common shares granted, 640,970 performance-based and 116,240 market-based restricted common shares granted under the 2012 Plan. As of May 31, 2017, there were 1,043,332 shares available for future issuance under the 2012 Plan. Service-based vesting condition options The fair value of each option award is estimated on the date of the grant using the Black-Scholes valuation model that uses the assumptions noted in the following table. Expected volatility is based on the historical volatility of the Company’s stock over the most recent period commensurate with the expected life of the Company’s stock options. The Company uses historical data to estimate option exercise and employee termination within the valuation model. The risk-free rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant. The expected term of options granted to employees is calculated, in accordance with the “simplified method” for “plain vanilla” stock options allowed under GAAP. Expected dividends are based on the historical trend of the Company not issuing dividends. There were 0 and 169,729 options granted during the three and six months ended May 31, 2017 and May 31, 2016, respectively. Variables used to determine the fair value of the options granted for the three and six months ended May 31, 2016 are as follows:
|  | Three Months Ended |  |  | Six Months Ended |
|  | May 31, 2016 |  |  | May 31, 2016 |
Weighted average values: |  |  |  |  |  |  |  |
Expected dividends |  |  | 0 | % |  |  | 0 | %
Expected volatility |  |  | 84.7 | % |  |  | 84.7 | %
Risk free interest rate |  |  | 1.24 | % |  |  | 1.24 | %
Expected life |  |  | 6 years |  |  |  | 6 years |
Stock option activity for options with only service-based vesting conditions for the six months ended May 31, 2017, was as follows:
|  | Options |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Life (Years) |  |  | Aggregate Intrinsic Value |
Outstanding at November 30, 2016 |  |  | 1,142,010 |  |  | $ | 2.36 |  |  |  | 4.99 |  |  | $ | 2,157,112 |
Granted |  |  | — |  |  |  | — |  |  |  |  |  |  |  | — |
Exercised |  |  | (26,781 | ) |  |  | 1.92 |  |  |  |  |  |  |  | 78,149 |
Expired/forfeited |  |  | (5,000 | ) |  |  | 1.36 |  |  |  |  |  |  |  | 21,275 |
Outstanding at May 31, 2017 |  |  | 1,110,229 |  |  | $ | 2.38 |  |  |  | 4.60 |  |  | $ | 3,590,126 |
Exercisable at May 31, 2017 |  |  | 1,037,405 |  |  | $ | 2.32 |  |  |  | 4.35 |  |  | $ | 3,411,901 |
The aggregate intrinsic value represents the total value of the difference between the Company’s closing stock price on the last trading day of the period and the exercise price of the options, multiplied by the number of in-the-money stock options that would have been received by the option holders had all option holders exercised their options on either May 31, 2017 or May 31, 2016, as applicable. The intrinsic value of the Company’s stock options changes based on the closing price of the Company’s stock. For the three and six months ended May 31, 2017, the Company issued 7,500 and 26,781 common shares to option holders who exercised options for $17,900 and $51,396, respectively. There were no options exercised during the three and six months ended May 31, 2016. Significant option groups outstanding and exercisable at May 31, 2017 and related price and contractual life information are as follows:
|  | Outstanding |  |  | Exercisable |
Range of Exercise Prices |  | Outstanding |  |  | Weighted Average Remaining Contractual Life (Years) |  |  | Weighted Average Exercise Price |  |  | Outstanding |  |  | Weighted Average Exercise Price |
$1.01 to $2.00 |  |  | 425,000 |  |  |  | 4.42 |  |  | $ | 1.73 |  |  |  | 425,000 |  |  | $ | 1.73 |
$2.01 to $3.00 |  |  | 458,000 |  |  |  | 3.05 |  |  | $ | 2.58 |  |  |  | 458,000 |  |  | $ | 2.58 |
$3.01 to $4.00 |  |  | 227,229 |  |  |  | 8.07 |  |  | $ | 3.18 |  |  |  | 154,405 |  |  | $ | 3.19 |
|  |  | 1,110,229 |  |  |  | 4.60 |  |  | $ | 2.38 |  |  |  | 1,037,405 |  |  | $ | 2.32 |
A summary of the status of the Company’s non-vested options as of May 31, 2017, and changes during the six months ended May 31, 2017, is presented below:
|  | Options |  |  | Weighted Average Grant-Date Fair Value |
Non-vested at November 30, 2016 |  |  | 97,406 |  |  | $ | 1.84 |
Granted |  |  | — |  |  |  | — |
Vested |  |  | (24,582 | ) |  |  | 1.85 |
Forfeited |  |  | — |  |  |  | — |
Non-vested at May 31, 2017 |  |  | 72,824 |  |  | $ | 1.84 |
As of May 31, 2017, there was approximately $91,000 of total unrecognized compensation cost related to non-vested share-based compensation arrangements granted under the 2006 Plan and the 2012 Plan. The cost is expected to be recognized over a weighted-average period of .53 years as of May 31, 2017. The total fair value of shares vested during the six months ended May 31, 2017 was approximately $45,000. During the second fiscal quarter of 2016, the Company entered into Amended and Restated Employment Agreements (“2016 Employment Agreements”) with each of the Company’s Co-CEOs. Per the 2016 Employment Agreements, each of the Co-CEOs is to receive base grant equity awards in the form of qualified options of the Company’s common stock. As of April 15, 2016, David Portnoy and Mark Portnoy were granted 70,270 and 59,459 options of the Company’s common stock, respectively. The options were issued under the Company’s 2012 Stock Plan and will vest 1/3 upon grant, 1/3 on December 1, 2016 and the remaining 1/3 on November 30, 2017. The fair value of these options vested as of May 31, 2017 was approximately $182,000 and is reflected as selling, general and administrative expenses in the accompanying consolidated statement of comprehensive income. As of May 31, 2017, there was approximately $62,000 of total unrecognized compensation cost related to the non-vested options of common stock and these will continue to vest as notated above and per the 2016 Employment Agreements through November 30, 2017. Performance and market-based vesting condition options There were no performance-based or market-based vesting condition options granted during the three and six months ended May 31, 2017 and May 31, 2016. As of May 31, 2017 and May 31, 2016, there were no performance or market-based vesting condition options outstanding. Restricted common shares During the first fiscal quarter of 2014, the Company entered into Amended and Restated Employment Agreements (“Employment Agreements”) with each of the Company’s Co-CEOs. The Employment Agreements provide for the grant of restricted shares of the Company’s common stock based on certain performance measures being attained by each of the Company’s Co-CEOs. The Employment Agreements provide that if David Portnoy and Mark Portnoy are employed by the Company on November 30, 2015, then no later than February 15, 2016, the Company will grant up to 186,487 and 162,163 shares of restricted common shares, respectively, based on certain performance thresholds, as defined in the agreements. The Company issued David Portnoy 118,062 shares and Mark Portnoy 102,663 shares during the first quarter of fiscal 2016. As of May 31, 2016, there was $0 of total unrecognized compensation cost related to the issuance of these shares of restricted common shares. As of April 15, 2016, the Company entered into Amended and Restated Employment Agreements (“Employment Agreements”) with each of the Company’s Co-CEOs. The Employment Agreements provide for the grant of shares of the Company’s common stock based on certain performance measures being attained by each of the Company’s Co-CEOs during fiscal year 2016. The Employment Agreements state if David Portnoy and Mark Portnoy are employed by the Company on November 30, 2016, then no later than February 28, 2017, the Company will grant up to 186,487 and 162,163 shares of common stock. Based upon the performance measures being attained, the Company granted 183,145 and 159,257 shares of common stock to David Portnoy and Mark Portnoy, respectively. The fair value of the shares granted for fiscal 2016 was approximately $1,252,000 and was reflected as selling, general and administrative expense in the consolidated statements of comprehensive income (loss) for the year ended November 30, 2016. There was $0 of total unrecognized compensation cost related to the fiscal 2016 performance measures as of May 31, 2017. As of May 31, 2017, the Company has recognized approximately $362,000 of compensation cost related to the fiscal 2017 performance measures and there was approximately $362,000 in unrecognized compensation cost related to the fiscal 2017 performance measures. As of April 18, 2016, the Company entered into a second Amendment Agreement (the “Amendment”), with the Company’s CIO Oleg Mikulinsky effective December 1, 2015, amending certain terms of the Amendment Agreement dated May 1, 2013 and Mikulinsky Employment Agreement dated March 5, 2012. The Amendment provides for the grant of shares of the Company’s common stock based on certain performance measures being attained by the Company during fiscal year 2016. The Amendment states if Executive is employed by the Company on November 30, 2016, then no later than February 28, 2017, the Company will grant Executive up to 20,000 shares of restricted stock based on performance as set forth in the Amendment. Based upon performance measures being attained, the Company granted 19,620 shares of common stock to Oleg Mikulinksy. The fair value of the shares granted was approximately $78,000. There was $0 of total unrecognized compensation cost as of May 31, 2017.

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for accounts comprising shareholders' equity, comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income, and compensation-related costs for equity-based compensation. Includes, but is not limited to, disclosure of policies, compensation plan details, equity-based arrangements to obtain goods and services, deferred compensation arrangements, and employee stock purchase plan details. + References No definition available. + Details
Name: | us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration